EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain–specific outcomes

Lauren A Chang, Eleanor Burgess, Moataz Noureddine, Anthony J Wells, Johanna Vandekerckhove, Juan García-Bernalt Diego, Brett T Webb, Leonie J Grüneberg, Seok-Chan Park, Gabriel Laghlali iD, Vivian Yan, Farah El-Ayache und 4 weitere

The Journal of Immunology · 01.10.2026 · 215 (10)

DOI: 10.1093/jimmun/vkag279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 29.10.2026. Verfasst von Lauren A Chang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Hauptthemen laut MEDLINE: Eosinophils, Orthomyxoviridae Infections, Influenza Vaccines. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophils are pleiotropic cells and can respond to a wide array of inflammatory stimuli, including respiratory viral infection. Although they are historically associated with adverse outcomes in vaccinated hosts after breakthrough infection, such as during vaccine-associated enhanced respiratory disease (VAERD) for respiratory syncytial virus (RSV), eosinophils can also help mediate antiviral immunity. We previously observed mild, nonpathological lung eosinophilia in vaccinated mice experiencing influenza breakthrough infection, distinct from VAERD. Here, we investigated the factors driving this eosinophil recruitment and their contribution to host outcomes during influenza breakthrough infection. Vaccine-elicited Abs partially mediate eosinophil recruitment to the lungs during infection but do not confer full protection against viral replication or disease. Live viral replication was needed for robust eosinophil recruitment. Furthermore, both CD4 and CD8 T cells were required for optimal eosinophil accumulation in the lungs. Intramuscular vaccination resulted in the induction of a balanced type 1/2 response in the spleen and mainly a type 2 response in the lung upon infection, whereas a type 1 immune response dominated in the lungs of unvaccinated mice upon infection. Eosinophil depletion studies revealed strain-dependent effects: in BALB/c mice, eosinophil depletion did not significantly affect morbidity, viral load, lung inflammation, or lung lesion severity. However, in C57BL/6 mice, eosinophil depletion improved viral control and reduced pro-inflammatory cytokine expression. Our findings highlight the complex interplay among vaccine-induced immunity, eosinophil recruitment, and host genetic background in shaping outcomes during influenza breakthrough infection, with implications for vaccine strategies and immunopathology mitigation in diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophilsOrthomyxoviridae InfectionsInfluenza VaccinesAnimalsMiceBreakthrough InfectionsMice, Inbred BALB CFemaleLungMice, Inbred C57BLVaccinationCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesSpecies SpecificityAntibodies, ViralVirus Replication

Stichwörter der Autor:innen

cytokineseosinophilinfluenza virustype 2 immunityvaccine

Substanzen

Influenza VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, United States.
  • Veterinary Diagnostic Laboratory, North Dakota State University, Fargo, ND, United States.
  • Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium.

ORCID-Profile: Gabriel Laghlali, Pamela T Wong, Amali E Samarasinghe, Michael Schotsaert

Förderung

  • NIAID NIH HHS
  • NIH
  • NIAID
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Center of Excellence for Influenza Research
  • Belgian American Educational Foundation
  • Center for Research on Influenza Pathogenesis and Transmission

Zitieren

APA

Chang, L. A., Burgess, E., Noureddine, M., Wells, A. J., Vandekerckhove, J., García-Bernalt Diego, J., Webb, B. T., Grüneberg, L. J., Park, S. C., Laghlali, G., Yan, V., El-Ayache, F., Lambrecht, B. N., Wong, P. T., Samarasinghe, A. E., & Schotsaert, M. (2026). Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain–specific outcomes. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag279

Vancouver

Chang LA, Burgess E, Noureddine M, Wells AJ, Vandekerckhove J, García-Bernalt Diego J, et al. Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain–specific outcomes. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag279

BibTeX
@article{Chang2026,
  author = {Chang, Lauren A and Burgess, Eleanor and Noureddine, Moataz and Wells, Anthony J and Vandekerckhove, Johanna and García-Bernalt Diego, Juan and Webb, Brett T and Grüneberg, Leonie J and Park, Seok-Chan and Laghlali, Gabriel and Yan, Vivian and El-Ayache, Farah and Lambrecht, Bart N and Wong, Pamela T and Samarasinghe, Amali E and Schotsaert, Michael},
  title = {Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain–specific outcomes},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {10},
  doi = {10.1093/jimmun/vkag279}
}
Kostenlos starten →